198 related articles for article (PubMed ID: 32975782)
1. A Comprehensive Methodology to Systematically Identify Drug Hypersensitivity and Anaphylactic Reactions in Clinical Trial Databases.
Xavier H; Hara I; Ottesen LH; Verheijen RB; Ghiorghiu D; Morgan C
Pharmaceut Med; 2020 Oct; 34(5):335-345. PubMed ID: 32975782
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of automated term groupings for detecting anaphylactic shock signals for drugs.
Souvignet J; Declerck G; Trombert B; Rodrigues JM; Jaulent MC; Bousquet C
AMIA Annu Symp Proc; 2012; 2012():882-90. PubMed ID: 23304363
[TBL] [Abstract][Full Text] [Related]
3. Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database.
Suwankesawong W; Saokaew S; Permsuwan U; Chaiyakunapruk N
BMC Complement Altern Med; 2014 Dec; 14():515. PubMed ID: 25539642
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database.
Zhao Y; Lu H; Thai S; Li X; Hui J; Tang H; Zhai S; Sun L; Wang T
Int J Clin Pharm; 2018 Aug; 40(4):862-869. PubMed ID: 29464448
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority.
Ribeiro-Vaz I; Marques J; Demoly P; Polónia J; Gomes ER
Eur J Clin Pharmacol; 2013 Mar; 69(3):673-81. PubMed ID: 22915040
[TBL] [Abstract][Full Text] [Related]
6. Reporting rates for severe hypersensitivity reactions associated with prescription-only drugs in outpatient treatment in Germany.
Sachs B; Fischer-Barth W; Merk HF
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1076-84. PubMed ID: 26285651
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced hypersensitivity: A 5-year retrospective study in a hospital electronic health records database.
Mendes D; Alves C; Loureiro M; Fonte A; Batel-Marques F
J Clin Pharm Ther; 2019 Feb; 44(1):54-61. PubMed ID: 30069891
[TBL] [Abstract][Full Text] [Related]
8. Incidence of hypersensitivity and anaphylaxis with sugammadex.
Min KC; Woo T; Assaid C; McCrea J; Gurner DM; Sisk CM; Adkinson F; Herring WJ
J Clin Anesth; 2018 Jun; 47():67-73. PubMed ID: 29621739
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBase™ and IQVIA™ MIDAS® over a ten-year period from 2008 to 2017.
Durup D; Schaffalitzky de Muckadell P; Strom CC
Expert Rev Hematol; 2020 May; 13(5):557-564. PubMed ID: 32129113
[No Abstract] [Full Text] [Related]
10. Spontaneous reports of hypersensitivity adverse drug reactions in Portugal: a retrospective analysis.
Mendes D; Oliveira AR; Alves C; Batel Marques F
Expert Opin Drug Saf; 2020 Jun; 19(6):763-769. PubMed ID: 32167395
[TBL] [Abstract][Full Text] [Related]
11. Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks.
Craig TJ; Li HH; Riedl M; Bernstein JA; Lumry WR; MacGinnitie AJ; Stolz LE; Biedenkapp J; Chyung Y
J Allergy Clin Immunol Pract; 2015; 3(2):206-212.e4. PubMed ID: 25609335
[TBL] [Abstract][Full Text] [Related]
12. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
Spoerl D; Nigolian H; Czarnetzki C; Harr T
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
[TBL] [Abstract][Full Text] [Related]
13. Drug safety and big clinical data: Detection of drug-induced anaphylactic shock events.
Bouzillé G; Osmont MN; Triquet L; Grabar N; Rochefort-Morel C; Chazard E; Polard E; Cuggia M
J Eval Clin Pract; 2018 Jun; 24(3):536-544. PubMed ID: 29532572
[TBL] [Abstract][Full Text] [Related]
14. Anaphylactoid reaction considered ciprofloxacin related: a case report and literature review.
Kelesidis T; Fleisher J; Tsiodras S
Clin Ther; 2010 Mar; 32(3):515-26. PubMed ID: 20399988
[TBL] [Abstract][Full Text] [Related]
15. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
Leone R; Conforti A; Venegoni M; Motola D; Moretti U; Meneghelli I; Cocci A; Sangiorgi Cellini G; Scotto S; Montanaro N; Velo G
Drug Saf; 2005; 28(6):547-56. PubMed ID: 15924506
[TBL] [Abstract][Full Text] [Related]
17. A Critical Evaluation of Safety Signal Analysis Using Algorithmic Standardised MedDRA Queries.
Tieu C; Breder CD
Drug Saf; 2018 Dec; 41(12):1375-1385. PubMed ID: 30112728
[TBL] [Abstract][Full Text] [Related]
18. Radiocontrast Media Hypersensitivity: Skin Testing Differentiates Allergy From Nonallergic Reactions and Identifies a Safe Alternative as Proven by Intravenous Provocation.
Trautmann A; Brockow K; Behle V; Stoevesandt J
J Allergy Clin Immunol Pract; 2019; 7(7):2218-2224. PubMed ID: 30980898
[TBL] [Abstract][Full Text] [Related]
19. Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications.
Chang LC; Mahmood R; Qureshi S; Breder CD
PLoS One; 2017; 12(6):e0178104. PubMed ID: 28570569
[TBL] [Abstract][Full Text] [Related]
20. Intradermal skin testing in the investigation of suspected anaphylactic reactions during anaesthesia--a retrospective survey.
Soetens FM; Smolders FJ; Meeuwis HC; Van der Donck AG; Van der Aa PH; De Vel MA; Vanhoof MJ; Soetens MA
Acta Anaesthesiol Belg; 2003; 54(1):59-63. PubMed ID: 12703347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
